Diabetes
- Newer diabetes drugs: Surprising shared benefits and unique side effects
The shared beneficial effects of the SGLT2 inhibitors and the GLP-1 receptor agonists, drugs with distinct mechanisms of action, may have an anti-inflammatory explanation.
- Glucagon-like peptide-1 receptor agonists and pancreatitis: A reconcilable divorce
Early trials suggested a link between GLP-1 receptor agonists and pancreatitis, but recent large meta-analyses do not support a class-wide risk.
- Managing the side effects of sodium-glucose cotransporter-2 inhibitors
The authors review recent evidence on the side effects of sodium-glucose cotransporter-2 inhibitors and corresponding strategies for preventing and managing them.
- Managing noninsulin glucose-lowering medications before surgery: A comparison of clinical practice guidelines
Recommendations for adjusting the treatment regimen of each class of noninsulin glucose-lowering agents before surgery are discussed.